World's Best Scientists 2026 revealed!
david i smith

david i smith

D-Index & Metrics

Genetics

D-Index
84
Citations
20112
World Ranking
1376
National Ranking
649

Medicine

D-Index
86
Citations
21513
World Ranking
14303
National Ranking
7231

david i smith publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where david i smith sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 197 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

david i smith D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where david i smith sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 84 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Cancer

His primary scientific interests are in Cancer research, Genetics, Chromosomal fragile site, Carcinogenesis and Gene. His studies deal with areas such as Mutation, Transfection, Lymphoma, Tumor suppressor gene and Virus Integration as well as Cancer research. His studies in Tumor suppressor gene integrate themes in fields like Lung cancer, AXIN2, Colorectal cancer and Exon.

His Chromosomal fragile site research includes themes of Fluorescence in situ hybridization, Aphidicolin, Cervical cancer and Genome instability. His work deals with themes such as Molecular biology and Virology, which intersect with Carcinogenesis. The study incorporates disciplines such as Bladder cancer and Urinary bladder in addition to Molecular biology.

His most cited work include:

  • Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. (431 citations)
  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss (270 citations)
  • A role for common fragile site induction in amplification of human oncogenes. (251 citations)

What are the main themes of his work throughout his whole career to date?

David I. Smith spends much of his time researching Genetics, Cancer research, Gene, Chromosomal fragile site and Molecular biology. His Cancer research research includes elements of Carcinogenesis, Cancer, Tumor suppressor gene, Cell and Mutation. His Cancer research is multidisciplinary, relying on both Carcinoma, Pathology and Oncology.

His Chromosomal fragile site study also includes fields such as

  • FHIT which intersects with area such as WWOX,
  • Fluorescence in situ hybridization which intersects with area such as Bacterial artificial chromosome. He interconnects Translocation Breakpoint, Messenger RNA and Gene mapping in the investigation of issues within Molecular biology. His study looks at the relationship between Loss of heterozygosity and topics such as Ovarian cancer, which overlap with Ovary.

He most often published in these fields:

  • Genetics (40.96%)
  • Cancer research (40.43%)
  • Gene (36.17%)

What were the highlights of his more recent work (between 2009-2020)?

  • Genetics (40.96%)
  • Cancer research (40.43%)
  • Gene (36.17%)

In recent papers he was focusing on the following fields of study:

His main research concerns Genetics, Cancer research, Gene, Cancer and DNA sequencing. His studies deal with areas such as Cell, Gene expression profiling, Transcriptome, microRNA and Lymphoma as well as Cancer research. His study on Chromosomal fragile site, RNA, Sequence analysis and Fusion gene is often connected to TP63 as part of broader study in Gene.

His Cancer study integrates concerns from other disciplines, such as Oncology and Untranslated region. His studies in DNA sequencing integrate themes in fields like Genome, Human genome, Genomics and Computational biology. His Human genome research is multidisciplinary, incorporating elements of Cervical cancer, Whole genome sequencing and Molecular biology.

Between 2009 and 2020, his most popular works were:

  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss (270 citations)
  • Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. (198 citations)
  • Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas (145 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

David I. Smith mainly investigates Genetics, Gene, Cancer research, Chromosomal fragile site and Exome sequencing. His research combines Cervical adenocarcinoma and Gene. David I. Smith combines subjects such as Gene expression profiling, Cervical cancer, Lymphoma, Pathology and microRNA with his study of Cancer research.

He works on Chromosomal fragile site which deals in particular with Chromosome Fragile Site. David I. Smith has included themes like Hereditary sensory and autonomic neuropathy, Cell cycle phase, DNA mismatch repair and Hereditary motor and sensory neuropathy in his Exome sequencing study. The concepts of his RNA study are interwoven with issues in Molecular biology and Gene knockdown.

Best Publications

  • Role for the p53 homologue p73 in E2F-1-induced apoptosis

    Meredith Irwin;Maria Carmen Marin;Andrew C. Phillips;Ratnam S. Seelan

  • Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

    Liu W;Dong X;Mai M;Seelan Rs

  • Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

    Haojie Huang;Kevin M. Regan;Fang Wang;Diping Wang

  • Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

    Ken Taniguchi;Lewis R Roberts;Ileana N Aderca;Xiangyang Dong

  • Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

    Karen H. Lu;Andrea P. Patterson;Lin Wang;Rebecca T. Marquez

  • Malignant pheochromocytoma: Current status and initiatives for future progress

    Graeme Eisenhofer;Stefan R. Bornstein;Frederieke M. Brouwers;Nai Kong V. Cheung

  • MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

    Penka S. Petrova;Andrei Raibekas;Jonathan Pevsner;Noel Vigo

  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss

    Christopher J. Klein;Maria Victoria Botuyan;Yanhong Wu;Christopher J. Ward

  • Mutations in CHEK2 associated with prostate cancer risk.

    Xiangyang Dong;Liang Wang;Ken Taniguchi;Xianshu Wang

  • Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations

    Wanguo Liu;David I. Smith;Keri J. Rechtzigel;Stephen N. Thibodeau

  • Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.

    Horacio Murillo;Haojie Huang;Lucy J. Schmidt;David I. Smith

  • Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

    Rebecca T. Marquez;Keith A. Baggerly;Andrea P. Patterson;Jinsong Liu

  • A role for common fragile site induction in amplification of human oncogenes.

    Asaf Hellman;Eitan Zlotorynski;Stephen W Scherer;Joseph Cheung

  • Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

    Erik C Thorland;Shannon L Myers;Bobbie S Gostout;David I Smith

  • Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

    Andrew L. Feldman;Ahmet Dogan;David I. Smith;Mark E. Law

  • Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

    M J Ferber;D P Montoya;C Yu;I Aderca

  • Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.

    Jinping Lai;Jeremy Chien;Julie K. Staub;Rajeswari Avula

  • Genetic Analysis of Early- versus Late-Stage Ovarian Tumors

    Viji Shridhar;Ajay Pandita;Rajeswari Avula;Julie Staub

  • Long, abundantly expressed non-coding transcripts are altered in cancer

    Damon S. Perez;Tiffany R. Hoage;Jay R. Pritchett;Allison L. Ducharme-Smith

  • Replication of a Common Fragile Site, FRA3B, Occurs Late in S Phase and is Delayed Further Upon Induction: Implications for the Mechanism of Fragile Site Induction

    Michelle M. Le Beau;Feyruz V. Rassool;Mary E. Neilly;Rafael Espinosa

Frequent Co-Authors

Lewis R. Roberts
Lewis R. Roberts Mayo Clinic
Lynn C. Hartmann
Lynn C. Hartmann Mayo Clinic
Kerry D. Olsen
Kerry D. Olsen Mayo Clinic
Haojie Huang
Haojie Huang Mayo Clinic
Jeremy Chien
Jeremy Chien University of California, Davis
Bruce W. Eckloff
Bruce W. Eckloff Mayo Clinic
Yan W. Asmann
Yan W. Asmann Mayo Clinic
George Vasmatzis
George Vasmatzis Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics can open doors to a variety of healthcare and research careers. Many students interested in genetics also pursue nursing and advanced clinical roles, and online degrees are making this progression more accessible than ever.

Aspiring nurse practitioners can benefit from online nurse practitioner programs that offer flexibility and affordability. Those aiming to accelerate their careers may consider cheapest accelerated nursing programs, which save both time and cost while providing high-quality education.

Advancing even further, there are specialized options like online dnp fnp programs for those interested in clinical leadership or advanced practice. Additionally, registered nurses can expand their qualifications through online rn to bsn programs, bridging the gap to baccalaureate credentials and opening more career opportunities in genetics, education, and research.

Exploring these online degree options allows students to tailor their career pathway in genetics and healthcare, matching educational goals with the evolving demands of the field.

Best Scientists Citing david i smith

Trending Scientists

Recently Published Articles